Ponesimod, sold under the brand name Ponvory, is a medication for the treatment of multiple sclerosis. It is a sphingosine-1-phosphate receptor modulator.
Ponesimod, sold under the brand name Ponvory, is a medication for the treatment of multiple sclerosis. It is a sphingosine-1-phosphate receptor modulator.
The most common side effects include upper respiratory tract infection, hepatic transaminase elevation, and hypertension.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).